TY  - GEN
AU  - Kirk,Allan D
AU  - Hale,Douglas A
AU  - Mannon,Roslyn B
AU  - Kleiner,David E
AU  - Hoffmann,Steven C
AU  - Kampen,Robert L
AU  - Cendales,Linda K
AU  - Tadaki,Douglas K
AU  - Harlan,David M
AU  - Swanson,S John
TI  - Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H)
SN  - 0041-1337
PY  - 2003///0904
KW  - Adult
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Neoplasm
KW  - Black People
KW  - Female
KW  - Follow-Up Studies
KW  - Graft Rejection
KW  - epidemiology
KW  - Graft Survival
KW  - drug effects
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Kidney Transplantation
KW  - immunology
KW  - Lymph Nodes
KW  - Lymphocyte Depletion
KW  - Male
KW  - Middle Aged
KW  - T-Lymphocytes
KW  - Time Factors
KW  - Transplantation, Homologous
KW  - United States
KW  - White People
KW  - Black or African American
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1097/01.TP.0000071362.99021.D9
ER  -